Exercise and geriatric assessment for older adults with colorectal cancer
Tests exercise and geriatric assessment for dizziness and walking problems in older colorectal cancer patients.
Plain-language title generated from the registry record
Registry title: The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
Key facts
- Where
- Copenhagen and Herlev, DenmarkSee the 2 sites
Where in Denmark
- Copenhagen University Hospital, RigshospitaletCopenhagen, DenmarkNot yet recruiting
- Copenhagen University Hospital - Herlev and Gentofte HospitalHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Trial code
- NCT05710809
- Record updated
- 6 April 2025
- Original description
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathyRead full original descriptionShow less
The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy
Inclusion: Meet the criteria of the oncological departments of receiving neoadjuvant, adjuvant or first line palliative chemotherapy for colorectal cancer; ≥65 years of age at the time of signing the informed consent form; Able to speak and read Danish, and to provide a signed informed consent form; Have an Eastern Cooperative Oncology Group (ECOG) performance status score of ≤2.
Exclusion: Chemotherapy treatment within two years and sequelae of neuropathy, or symptoms of dizziness or vertigo, or balance disturbance; Dementia, psychotic disorders, or other cognitive diseases or conditions that hinder participation in a clinical exercise-based trial; Severe physical disability that hinders physical exercise; Inability to sign informed content; Patients who have had a consultation in the geriatric outpatient clinic within the past six months.